NEW YORK (GenomeWeb News) - Roche Diagnostics has agreed to a settlement offer from Ambry Genetics in a case involving patent infringement for Roche’s polymerase chain reaction and related technology, Roche said today.
 
Under the settlement, Roche has agreed to drop arbitration proceedings against the Ambry in return for payment of past royalties of an undisclosed amount in the field of human in vitro diagnostics.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.